The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT).
 
Ashley Hanlon
No Relationships to Disclose
 
Steven Fleming
No Relationships to Disclose
 
Ann S Hamilton
No Relationships to Disclose
 
Michaela Ann Dinan
No Relationships to Disclose
 
Chiara Melloni
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ferring (Inst); GlaxoSmithKline (Inst); Luitpold Pharmaceuticals (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); St. Jude Medical (Inst)
 
Michael Roger Harrison
Consulting or Advisory Role - Bayer; Exelixis; Genentech; Sanofi
Speakers' Bureau - Genentech
Research Funding - Argos Therapeutics; Bristol-Myers Squibb; Genentech; Medivation/Astellas; Pfizer
 
Michel Khouri
No Relationships to Disclose
 
Xiao-cheng Wu
No Relationships to Disclose
 
J. Frank Wilson
No Relationships to Disclose
 
Joseph Lipscomb
No Relationships to Disclose
 
Rosemary Donaldson Cress
No Relationships to Disclose
 
Roger T Anderson
No Relationships to Disclose
 
Gretchen Genevieve Kimmick
Research Funding - Abraxis BioScience (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst); Wyeth (Inst)
Travel, Accommodations, Expenses - Genomic Health; other (I)